Gilead’s Lenacapavir, Takeda’s Maribavir Due For Oral Explanations At EMA

 
• By Vibha Sharma

The sponsors of four drugs were due or possibly due to appear before the European Medicines Agency to explain why their respective products merit EU-wide approval.  

Concept of EMA European Medicines Agency. Drugs evaluation and quality control, standards compliance department.
Oral explanations give companies a chance to explain why their drugs deserve EU-wide approval • Source: Shutterstock

More from Europe

More from Geography